MicroSintesis is a new life sciences company focused on creating novel anti-infectives. By harnessing the natural defense mechanisms of probiotics, MicroSintesis is on the forefront of developing biotechnologies that fight antibiotic resistant bacteria and reduce the virulence of pathogens.